Gibson, Dunn & Crutcher LLP has advised US WorldMeds on the transaction, and Ropes & Gray LLP has advised Adaptimmune Therapeutics plc. US WorldMeds has entered...
US WorldMeds Acquires Adaptimmune’s Cell Therapy Portfolio for $55 Million
MiddleGround Capital’s Acquisition of The L.S. Starrett Company
Dechert advised MiddleGround Capital, while Ropes & Gray served as legal counsel to Starrett on the deal. MiddleGround Capital, a private equity firm, announced their definitive...
Pfizer’s Strategic Collaboration with Flagship Pioneering
Ropes & Gray advised Pfizer on the deal. Pfizer announced a strategic collaboration with Flagship Pioneering to create a new pipeline of innovative medicines. The collaboration...
BDT Capital Partners’ $125 Million Preferred Equity Investment in National Amusements
Ropes & Gray advised National Amusements Inc. on the deal. National Amusements, Inc, the majority voting shareholder of Paramount Global, announced that it has entered into...
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
CVS Health’s $8 Billion Acquisition of Signify Health
Fried, Frank, Harris, Shriver & Jacobson, Dechert, and McDermott Will & Emery advised CVS Health, while Ropes & Gray advised Signify Health on the deal. Skadden...
Pfizer’s Acquisition of Biohaven Pharmaceutical
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...
Merck’s $11.5 Billion Acquisition of Acceleron Pharma
Covington & Burling and Gibson, Dunn & Crutcher advised Merck, while Ropes & Gray advised Acceleron. Skadden, Arps, Slate, Meagher & Flom represented Centerview Partners LLC...
Medtronic’s $1 Billion Acquisition of Intersect ENT
Cooley advised Intersect ENT on the deal, while Ropes & Gray advised Medtronic. Intersect ENT, a global ear, nose and throat medical technology leader dedicated to...